CMS Now Covers Blood-Based Biomarker Screening for Colorectal Cancer

June 10, 2021

Recognizing that blood-based biomarker tests have emerged as another potential non-invasive option for the early detection of CRC, the Centers for Medicare & Medicaid Services (CMS) has announced that it is extending coverage for these services under Medicare Part B. In releasing the new National Coverage Determination, CMS stated that it will reimburse services performed after January 19, 2021, once every three years for Medicare patients when performed in a laboratory certified under the Clinical Laboratory Improvement Amendments. To learn more about the specifics necessary for reimbursement, click here.

To read more articles from this issue of ePolicy, click here. To learn more about ePolicy News and access past newsletters and articles, click here.

For more information regarding ASCP's advocacy initiatives and policy positions, please contact ASCP's Center for Public Policy at (202) 408-1110.

sponsors_hologic
ASCP ePolicy News is supported by an unrestricted grant from Hologic.

First Name *
Last Name *
Email *
Customer ID

Name *
Country Code *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id